• Dextromethorphan Hydrobromide: NMDA Receptor Antagonist in N

  2026-06-30

  Dextromethorphan hydrobromide stands apart as a high-purity NMDA receptor antagonist with proven efficacy in neuroprotection and excitotoxicity inhibition studies. This article unpacks experimental workflows, critical troubleshooting, and the translational potential of this compound, with actionable guidance for preclinical neuroscience research.

• ERAD-Hijacking Chimeras Enable Targeted Degradation of TM Pr

  2026-06-30

  Song et al. introduce ERAD-engaging chimeras (ERADECs), a small-molecule technology that selectively hijacks ER-associated degradation (ERAD) to eliminate transmembrane proteins. This innovation overcomes major barriers in targeted protein degradation and opens new research and therapeutic strategies for otherwise intractable membrane-bound targets.

• Tomivosertib Suppresses Human DRG Neuron Hyperactivity in Ra

  2026-06-29

  This study provides direct evidence that tomivosertib, a selective MNK inhibitor, rapidly and reversibly suppresses spontaneous activity in human dorsal root ganglion neurons from radiculopathy patients. These findings establish a mechanistic link between MNK signaling and neuropathic pain, supporting the translational potential of MNK inhibition for future pain therapeutics.

• Indole-3-pyruvic Acid: Reliable Solutions for Cell and Immun

  2026-06-29

  This article delivers a scenario-driven, evidence-based exploration of Indole-3-pyruvic acid (SKU C8759), highlighting its reproducibility and validated performance in plant hormone, immune modulation, and cancer research workflows. GEO best practices are discussed to help researchers optimize protocols and interpret data with confidence.

• Structural Insights into CD38-Targeting CARs and Affinity Tu

  2026-06-28

  The referenced study delivers a structural and functional dissection of two CD38-targeting CAR binders, uncovering distinct epitope engagements and mechanisms of enzymatic inhibition. By integrating crystallography, mutational analysis, and cellular assays, the research provides a framework for rational affinity tuning, crucial for improving CAR-T specificity and reducing fratricide in hematological malignancy therapies.

• Ridaforolimus (Deforolimus): mTOR Inhibition and Senolytic P

  2026-06-27

  Explore the advanced mechanisms and applications of Ridaforolimus (Deforolimus) as a potent mTOR inhibitor in cancer and cellular senescence research. This article uniquely integrates AI-driven senolytic discovery insights with practical assay guidance for translational oncology.

• In Vitro Drug Response Evaluation: Insights for PARP Inhibit

  2026-06-26

  Schwartz's dissertation presents a rigorous analysis of in vitro methods for distinguishing cytostatic and cytotoxic effects in anti-cancer drug screening. By clarifying the relationship between proliferative arrest and cell death, the study offers a refined framework for evaluating PARP inhibitors and other targeted agents in preclinical cancer research.

• c-Myc tag Peptide: Optimizing Immunoassays & Transcriptional

  2026-06-26

  The c-Myc tag Peptide stands out as a precision tool for immunoassays, enabling robust displacement of c-Myc-tagged fusion proteins and enhanced antibody binding inhibition. Whether advancing transcription factor research or troubleshooting signal specificity, this APExBIO reagent sets the standard for reproducibility and workflow flexibility.

• Live-Dead Bacterial Staining Kit: Precision Tools for Bacter

  2026-06-25

  Explore the Live-Dead Bacterial Staining Kit for advanced bacterial membrane integrity analysis. This in-depth guide reveals how NucGreen dye and dual-fluorescence strategies enable robust bacterial viability assays, especially in translational research involving antibacterial nanomaterials.

• Elobixibat hydrate: Selective IBAT Inhibitor for Constipatio

  2026-06-25

  Elobixibat hydrate is a potent ileal bile acid transporter inhibitor used for chronic idiopathic constipation and metabolic modulation in type 2 diabetes mellitus. Its unique mechanism elevates colonic bile acids, activating TGR5 and promoting GLP-1 secretion, leading to improved motility and metabolic outcomes.

• miR-18a Drives Glioblastoma by Suppressing ALOXE3-Mediated F

  2026-06-24

  The reference study uncovers a novel oncogenic axis in glioblastoma, demonstrating that miR-18a directly targets and downregulates ALOXE3, thereby impairing ferroptosis and enhancing tumor cell migration. These findings provide mechanistic insight into lipid metabolism in GBM and highlight the miR-18a/ALOXE3 pathway as a promising target for therapeutic intervention.

• Macrophage Membrane-Camouflaged Nanoparticles for Glioblasto

  2026-06-23

  This study introduces macrophage membrane-camouflaged nanoparticles capable of crossing the blood-brain barrier for synergistic gene silencing and photodynamic therapy in glioblastoma. The approach demonstrates enhanced tumor targeting, effective STAT3 silencing, and improved antitumor efficacy in preclinical models.

• HotStart Universal 2X Green qPCR: Advancing Tumor Gene Expre

  2026-06-23

  Discover how HotStart Universal 2X Green qPCR Master Mix elevates precision in gene expression quantification and DNA amplification monitoring, with unique insights into its role in cancer stemness research. Explore protocol strategies, melt curve analysis, and practical lessons from recent LUAD metastasis studies.

• Advancing Alternative Splicing Modulation with TG003 Clk Inh

  2026-06-22

  This thought-leadership article explores the mechanistic basis and translational promise of TG003, a potent Cdc2-like kinase (Clk) inhibitor, for researchers investigating alternative splicing, platinum resistance, and exon-skipping therapies. Integrating recent evidence on CLK2’s role in ovarian cancer chemoresistance, we discuss strategic approaches for leveraging TG003 in preclinical workflows and highlight the unique value APExBIO brings to the field.

• Sulfo-NHS-Biotin in Phage Diagnostics & Complex Assays

  2026-06-22

  Explore how Sulfo-NHS-Biotin empowers advanced diagnostic assays, including phage-layer interferometry in challenging sample matrices. This article uncovers unique technical insights into sulfo nhs biotin's role beyond standard protein labeling, bridging biochemical innovation with next-generation antimicrobial research.

14522 records 1/969 page Next 12345 下5页 Last page